![Luis Peña](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Luis Peña
Oprichter bij
EVOMMUNE, INC.
Vermogen: 15 M $ op 31-05-2026
Profiel
Luis C.
Peña was the founder of Dermira, Inc., founded in 2010, where the title held was Chief Development Officer.
Mr. Peña is the founder of Evommune, Inc., founded in 2020, holding the titles of President, Chief Executive Officer & Director.
Former jobs include Senior Director-Project Planning & Management at Innoviva, Inc., Principal at Genentech, Inc., Vice President-Portfolio Planning & Management at Connetics Corp.
from 2005 to 2007, Vice President-Product Development at Nuvelo, Inc. from 2001 to 2005, and VP & Head-Global Prescription Development at Stiefel Laboratories, Inc. from 2010 to 2011.
Education includes undergraduate studies at San Francisco State University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
EVOMMUNE, INC. 1,77% | 01-06-2026 | 637.896 ( 1,77% ) | 15 M $ | 31-05-2026 |
Actieve functies van Luis Peña
| Bedrijven | Functie | Begin |
|---|---|---|
| EVOMMUNE, INC. | Oprichter | 01-04-2020 |
Eerdere bekende functies van Luis Peña
| Bedrijven | Functie | Einde |
|---|---|---|
Stiefel Laboratories, Inc.
 Stiefel Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 01-03-2011 |
Connetics Corp.
 Connetics Corp. BiotechnologyHealth Technology Develops and commercializes dermatology products | Corporate Officer/Principal | 01-01-2007 |
Nuvelo, Inc.
 Nuvelo, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic drugs using genomic technologies | Corporate Officer/Principal | 01-01-2005 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | - |
| INNOVIVA, INC. | Corporate Officer/Principal | - |
Opleiding van Luis Peña
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
60
Eerstegraads connecties
8
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 8 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Connetics Corp.
Connetics Corp. BiotechnologyHealth Technology Develops and commercializes dermatology products | Health Technology |
Nuvelo, Inc.
Nuvelo, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic drugs using genomic technologies | Health Technology |
Innoviva, Inc.
 Innoviva, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that manufactures respiratory drugs | Health Technology |
San Francisco State University
 San Francisco State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stiefel Laboratories, Inc.
Stiefel Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Dermira, Inc.
 Dermira, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products to patients living with chronic skin conditions | Health Technology |
Evommune, Inc.
 Evommune, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that develops therapies for chronic inflammatory diseases | Health Technology |
